Literature DB >> 30030162

Genome-wide analysis of H3K36me3 and its regulations to cancer-related genes expression in human cell lines.

Lu-Qiang Zhang1, Qian-Zhong Li2, Wen Jin1, Yongchun Zuo3, Shu-Chun Guo4.   

Abstract

H3K36me3 is a histone modification known to mark active genes. To further understand the effects of H3K36me3 on gene expression levels, we develop predictive models to compute the correlation between the binding signal of H3K36me3 in each bin and the gene expression levels. We find that the bins with stronger H3K36me3 averaged-binding signals present higher correlative strengths with the expression levels of gene. And the higher correlative strengths appear in the downstream regions of the transcription start site. Moreover, we systematically compare the predictive abilities of 11 histone modifications to gene expression levels. The results show that H3K36me3 achieves a higher predictive ability than other modifications, and the higher predictive ability is robust across different mammalian cells and gene groups. Finally, in contrast to the two normal cell lines, our analysis finds that the predictive abilities of H3K36me3 are enhanced in 10 of the 13 bins for oncogenes and are decreased in 10 of 16 bins for tumor-suppressor genes in the cancer cell.
Copyright © 2018 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  H3K36me3; Histone modifications; Oncogenes; Tumor-suppressor genes

Mesh:

Year:  2018        PMID: 30030162     DOI: 10.1016/j.biosystems.2018.07.004

Source DB:  PubMed          Journal:  Biosystems        ISSN: 0303-2647            Impact factor:   1.973


  8 in total

1.  Microarray-based Analysis of Genes, Transcription Factors, and Epigenetic Modifications in Lung Cancer Exposed to Nitric Oxide.

Authors:  Arnatchai Maiuthed; Ornjira Prakhongcheep; Pithi Chanvorachote
Journal:  Cancer Genomics Proteomics       Date:  2020 Jul-Aug       Impact factor: 4.069

2.  Identification of Key Histone Modifications and Their Regulatory Regions on Gene Expression Level Changes in Chronic Myelogenous Leukemia.

Authors:  Lu-Qiang Zhang; Guo-Liang Fan; Jun-Jie Liu; Li Liu; Qian-Zhong Li; Hao Lin
Journal:  Front Cell Dev Biol       Date:  2021-01-12

3.  Pterostilbene Changes Epigenetic Marks at Enhancer Regions of Oncogenes in Breast Cancer Cells.

Authors:  Sadaf Harandi-Zadeh; Cayla Boycott; Megan Beetch; Tony Yang; Benjamin J E Martin; Kevin Ren; Anna Kwasniak; John H Dupuis; Katarzyna Lubecka; Rickey Y Yada; LeAnn J Howe; Barbara Stefanska
Journal:  Antioxidants (Basel)       Date:  2021-07-30

4.  EGFR transcription in non-small-cell lung cancer tumours can be revealed in ctDNA by cell-free chromatin immunoprecipitation (cfChIP).

Authors:  Christoffer Trier Månsson; Johan Vad-Nielsen; Peter Meldgaard; Anders Lade Nielsen; Boe Sandahl Sorensen
Journal:  Mol Oncol       Date:  2021-09-18       Impact factor: 6.603

Review 5.  H3K36 trimethylation-mediated biological functions in cancer.

Authors:  Chu Xiao; Tao Fan; He Tian; Yujia Zheng; Zheng Zhou; Shuofeng Li; Chunxiang Li; Jie He
Journal:  Clin Epigenetics       Date:  2021-10-29       Impact factor: 6.551

Review 6.  Genetic Biomarkers in Chronic Myeloid Leukemia: What Have We Learned So Far?

Authors:  Bilal Abdulmawjood; Beatriz Costa; Catarina Roma-Rodrigues; Pedro V Baptista; Alexandra R Fernandes
Journal:  Int J Mol Sci       Date:  2021-11-19       Impact factor: 5.923

Review 7.  NSD2 as a Promising Target in Hematological Disorders.

Authors:  Alba Azagra; César Cobaleda
Journal:  Int J Mol Sci       Date:  2022-09-21       Impact factor: 6.208

8.  Recognition of driver genes with potential prognostic implications in lung adenocarcinoma based on H3K79me2.

Authors:  Lu-Qiang Zhang; Hao Yang; Jun-Jie Liu; Li-Rong Zhang; Yu-Duo Hao; Jun-Mei Guo; Hao Lin
Journal:  Comput Struct Biotechnol J       Date:  2022-10-07       Impact factor: 6.155

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.